David Rossow serves as the Founding Partner of the Strategic Investment Fund at the Bill & Melinda Gates Foundation, where oversight of program-related investments spans global health, global development, gender equality, and US education within a $2.5 billion allocation. In addition to this role, David holds board observer positions at several companies, including bKash Limited, Halodoc ID, LumiraDx, Affinivax Inc., Kymab Ltd, Stellapps Technologies Private Limited, Immunocore, CureVac AG, and Visterra Inc., contributing to diverse industries such as mobile payments, healthcare, and biotechnology. David's extensive experience in strategic investments and board governance in various sectors highlights a strong commitment to fostering innovation and addressing global challenges. David is an alumnus of St. Olaf College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices